Groundbreaking Genomic Test Forecasts Hormone Therapy Benefits in Recurrent Prostate Cancer Treatment
A groundbreaking clinical study has unveiled a transformative biomarker that could revolutionize treatment strategies for recurrent prostate cancer patients post-surgery. ...
